1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The formal care costs of dementia : a longitudinal study using Swedish register data
2024) In European Journal of Health Economics(
- Contribution to journal › Article
- 2023
-
Mark
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
(
- Contribution to journal › Article
- 2022
-
Mark
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
(
- Contribution to journal › Article
- 2016
-
Mark
Labor market consequences of childhood onset type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Effect of Type 1 Diabetes on School Performance in a Dynamic World : New Analysis Exploring Swedish Register Data
(
- Working paper/Preprint › Working paper
- 2014
-
Mark
Childhood Health and Labor Market Outcomes in the Case of Type 1 Diabetes
2014) In Working Paper / Department of Economics, School of Economics and Management, Lund University(
- Working paper/Preprint › Working paper